1083049-80-2

Upstream product

• 1082937-67-4 C₂₂H₂₇ClN₄O₅S 
• 395639-03-9 bis(1,1-dimethylethyl)(4-nitrophenyl)imidocarbonate 
• 100-01-6 4-nitro-aniline 
• 71026-66-9 N-(tert-butoxycarbonyl)-1,4-phenylenediamine 
• 18437-63-3 tert-butyl N-(4-nitrophenyl)carbamate 
• 1082937-58-3 C₂₃H₂₃N₃O₆ 
• 1082937-62-9 C₂₀H₂₂ClN₃O₅S 
• 1082937-55-0 C₂₂H₂₅N₃O₅ 
• 1082937-60-7 C₁₅H₂₁N₃O₄ 

Downstream Products

• 1082936-67-1 C₁₉H₁₉ClN₄O₃S 
• 1082936-94-4 C₂₃H₂₀ClN₅O₃S 
• 1082936-73-9 C₂₀H₂₁ClN₄O₃S 

Relevant academic research and scientific papers

FXA INHIBITORS WITH CYCLIC AMIDINES AS P4 SUBUNIT, PROCESSES FOR THEIR PREPARATIONS, AND PHARMACEUTICAL COMPOSITIONS AND DERIVATIVES THEREOF

The present invention relates to novel oxazolidinone derivatives with cyclic araidines, and prodrugs, hydrates, solvates, isomers and pharmaceutically acceptable salts thereof, and processes for preparing the same, and pharmaceutical compositions comprising the same. The oxazolidinone derivatives with cyclic amidines, and prodrugs, hydrates, solvates, isomers and pharmaceutically acceptable salts thereof can be usefully employed as an anticoagulant for treating thromboembolism and tumors via inhibition of coagulation factor Xa.